AI English summary of an SEC filing — figures as filed

The company said revenue for Q4 2024 was $2.41 billion, up 25% from $1.93 billion a year earlier. It cited growth in da Vinci procedure volume and a larger installed base of systems as the drivers of the increase.

8-KResults of Operations and Financial ConditionFiled Jan 23, 2025Period of report Jan 21, 2025Summary published (UTC) Oct 9, 2026

Key points

AI summary

The company said revenue for Q4 2024 was $2.41 billion, up 25% from $1.93 billion a year earlier. It cited growth in da Vinci procedure volume and a larger installed base of systems as the drivers of the increase.
Intuitive said GAAP net income attributable to the company for Q4 2024 was $686 million ($1.88 per diluted share), and non-GAAP net income was $805 million ($2.21 per diluted share). The comparable figures a year earlier were $606 million ($1.69) and $574 million ($1.60), respectively.
Intuitive said it signed a definitive agreement to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino and associated territories from its current technology distributors ab medica, Abex, Excelencia Robotica and their affiliates, with the signing on January 21, 2025. The upfront cash payment is approximately €290 million, plus up to €31 million in commercial milestone payments, subject to certain closing adjustments. The company expects to complete the transaction in the first half of 2026.
The company said it expects worldwide da Vinci procedures to grow about 13% to 16% in 2025 compared with 2024, and its non-GAAP gross profit margin to be between 67% and 68% of net revenue, versus 69.1% in 2024. It said this range does not include the potential impact of new tariffs.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Intuitive reports Q4 2024 revenue of $2.41 billion, up 25% year over year

The company said revenue for Q4 2024 was $2.41 billion, up 25% from $1.93 billion a year earlier. It cited growth in da Vinci procedure volume and a larger installed base of systems as the drivers of the increase.

Source · Based on the filing body and exhibits

Intuitive reports Q4 2024 GAAP and non-GAAP net income attributable to the company

Intuitive said GAAP net income attributable to the company for Q4 2024 was $686 million ($1.88 per diluted share), and non-GAAP net income was $805 million ($2.21 per diluted share). The comparable figures a year earlier were $606 million ($1.69) and $574 million ($1.60), respectively.

Source · Based on the filing body and exhibits

Intuitive to buy da Vinci and Ion distributors in Italy and Spain (upfront €290 million)

Intuitive said it signed a definitive agreement to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino and associated territories from its current technology distributors ab medica, Abex, Excelencia Robotica and their affiliates, with the signing on January 21, 2025. The upfront cash payment is approximately €290 million, plus up to €31 million in commercial milestone payments, subject to certain closing adjustments. The company expects to complete the transaction in the first half of 2026.

Source · Based on the filing body and exhibits

Intuitive outlines 2025 da Vinci procedure growth and non-GAAP gross margin outlook

The company said it expects worldwide da Vinci procedures to grow about 13% to 16% in 2025 compared with 2024, and its non-GAAP gross profit margin to be between 67% and 68% of net revenue, versus 69.1% in 2024. It said this range does not include the potential impact of new tariffs.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.